Speaker Profile

___	__
	Biography Dr. Sarah McDonald is a Maternal-Fetal Medicine specialist and Professor in the Department of Obstetrics and Gynecology at McMaster University. Her research as a Clinician-Scientist is supported by a Tier II Canada Research Chair. Her research focuses on prevention and prevention of preterm birth and its sequelae. She is excited to be working with Canadian and Australian clinicians, researchers and parents to answer the question of whether one dose of betamethasone gives similar newborn outcomes as two doses in The Single Dose of Antenatal Corticosteroids (SNACS) Randomized Control Trial for Pregnancies at Risk of Preterm Delivery. Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Membership on advisory boards or speakers’ bureaus: 1) CIHR Institute Advisory Board (IAB) for the Institute of Human Development, Child and Youth Health; 2) External Advisory Committee (EAC) of the Public Health Agency of Canada’s Canadian Perinatal Surveillance System (CPSS) - Funded grants or clinical trials: 1. CIHR (clinical trial, grants, Canada Research Chair); 2. Australian Medical Research Future Fund (clinical trial); 3. Hamilton Academic Health Sciences Organization Academic Health Science Centre Alternate Funding Plan (grant) 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Sarah McDonald is a Maternal-Fetal Medicine specialist and Professor in the Department of Obstetrics and Gynecology at McMaster University. Her research as a Clinician-Scientist is supported by a Tier II Canada Research Chair. Her research focuses on prevention and prevention of preterm birth and its sequelae. She is excited to be working with Canadian and Australian clinicians, researchers and parents to answer the question of whether one dose of betamethasone gives similar newborn outcomes as two doses in The Single Dose of Antenatal Corticosteroids (SNACS) Randomized Control Trial for Pregnancies at Risk of Preterm Delivery.
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Membership on advisory boards or speakers’ bureaus: 1) CIHR Institute Advisory Board (IAB) for the Institute of Human Development, Child and Youth Health; 2) External Advisory Committee (EAC) of the Public Health Agency of Canada’s Canadian Perinatal Surveillance System (CPSS) - Funded grants or clinical trials: 1. CIHR (clinical trial, grants, Canada Research Chair); 2. Australian Medical Research Future Fund (clinical trial); 3. Hamilton Academic Health Sciences Organization Academic Health Science Centre Alternate Funding Plan (grant) 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).